Ramachandran Niro Ph.D 4
4 · Akoya Biosciences, Inc. · Filed Feb 27, 2023
Insider Transaction Report
Form 4
Ramachandran Niro Ph.D
Chief Business Officer
Transactions
- Award
Common Stock
2023-02-23+22,500→ 179,180 total - Award
Employee Stock Option (Right to Buy)
2023-02-23+45,000→ 45,000 totalExercise: $12.30Exp: 2033-02-23→ Common Stock (45,000 underlying)
Footnotes (3)
- [F1]The restricted stock units shall vest in four (4) equal annual installments beginning on the first anniversary of the grant date and on each anniversary thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Akoya Biosciences, Inc. common stock.
- [F3]The options shall vest as follows: twenty-five percent (25%) shall vest on the first anniversary of the grant date with the remainder vesting in 36 equal monthly installments beginning on March 23, 2024.